Welcome to your Upjohn portal. Thank you for signing up! Formalising Upjohn’s transition to wholesale distribution, Upjohn has signed contracts with another four wholesale distribution partners, including Sigma, API (Australian Pharmaceutical Industries), CH2 (Clifford Hallam Healthcare) and CHS (Central Healthcare Services), building on its first wholesale distribution agreement signed with Symbion in December. . “Upjohn’s decision will ensure community and hospital pharmacies in Australia continue to have access to our portfolio of medicines, which is our utmost priority,” Mr Richmond said. The companies have satisfied EC’s condition and received necessary approvals in Australia and New Zealand. PHARMACY owners in Victoria are voicing concerns over their stores’ future viability after being excluded from the latest round of State Government Business Support Fund grants (PD 23 Sep). Learn more about our portfolio. Addressing Australia’s overdose problem ... New recommendations for patients with mild asthma. “This is an important step for Upjohn in Australia that will enable us to establish a distribution model independent of Pfizer Australia and to ensure patients continue to have access to our medicines,” Mr Richmond said in a … Upjohn General Manager Australia and New Zealand Gareth Richmond said the repositioning of the distribution of Upjohn medicines with wholesalers is a commercial decision to ensure the business is in the best position for growth going forward. Our Products. Have you ever encountered stock management issues, incorrect pricing across your stores, individual stores ordering too much stock or one of your stores making an inconsistent gross profit? CPD). As a result, we’re able to both innovate and execute quickly, from activating our portfolio to improving manufacturing to advancing research and development. Although uncommon, sudden permanent hearing loss seems to be linked to Covid-19 infection in some people, warn doctors, reporting the first UK case in... Laws surrounding vaping regulations and nicotine e-liquids are inciting much controversy in the industry. Whether you’re working from home in the new Covid-19 safe world or back in the office, everyone knows healthy employees are more productive. Our Products. The 2020 recipient of the Australian Clinical Pharmacy Award, from the Society of Hospital Pharmacists of Australia (SHPA), is Dr Erica Tong. Learn more about Upjohn. “We are working closely with our wholesaler partners and the point-of-sale system providers to ensure the move to the wholesaler model is operationally aligned, and that customers and patients have a seamless experience during this period,” he said. Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription. Inspired by the heritage of a company known for its pioneering science, Upjohn harnesses the power of 20 of Pfizer's most iconic established biopharmaceutical brands – across therapeutic areas including Cardiovascular, Pain, Psychiatry, and Urology – by thinking strategically and operating nimbly. Please enter your login details. 11-17... Our top five tips to simplify your multi-store operations, A strong focus on alcohol linked with dementia, International Day of Women and Girls in Science, Call for government to stand firm around vaping regulations, SHPA’s 2020 Clinical Pharmacy Award winner, Political parties to support pharmacists in Queensland, Healthy Head Start for Workplaces this National Nutrition Week, Daily washing of cloth masks required to reduce virus transmission. As an organisation committed to putting patients first, Pfizer has always evolved with the changing needs of the people who rely on us to create a healthier world. And with roots in innovation and technological ingenuity, Upjohn is poised to take our portfolio of established medicines to the next level, bringing life-changing medicines to patients around the world and trailblazing a new path for the industry. About Upjohn. : ). Upjohn is an off-patent branded and established medicines business, which in Australia markets 18 off-patent medicines and globally, markets 20 off-patent brands. This field is for validation purposes and should be left unchanged. Are you a health professional registered with AHPRA? The publication launched in March 2007 and is distributed every day by email to pharmacists across the country. About Upjohn. Upjohn’s transition to the wholesale model will mean that from 24 February 2020, Upjohn will only distribute its medicines to pharmacies through Community Service Obligation (CSO) pharmaceutical wholesalers. We have always understood the importance a pharmacy has on its community and with an in-depth integrated approach we have provided the most up to date information for both the pharmacy-specific and retail- related business. FREE Pharmacy Daily subscription - never miss another story! Inspired by the heritage of a company known for its pioneering science, Upjohn harnesses the power of 20 of Pfizer's most iconic established biopharmaceutical brands – across therapeutic areas including Cardiovascular, Pain, Psychiatry, and Urology – by thinking strategically and operating nimbly. See our brands. Upjohn Australia splits from Pfizer Direct December 18, 2019 PFIZER has confirmed that its off-patent branded and established medicines business, Upjohn Australia, will transition to a traditional distribution model through Community Service Obligation (CSO) wholesalers in Feb 2020 (PD breaking news). For nearly three decades, Retail Pharmacy has been the leading trade publication in the pharmacy industry. PHARMACY software provider, Fred IT Group’s role in the introduction of electronic prescriptions has seen the business named as the winner of the 2020 Victorian iAward for Business and Industry Solution of the Year. Poised to take our portfolio of … Pfizer Finance Director Bradley Apps said Pfizer’s BioPharmaceutical business continues to remain an important part of Pfizer’s business in Australia and New Zealand, and despite Upjohn’s move to wholesale distribution it is business as usual for Pfizer BioPharma.